|
PEX3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
6.7655003821443E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
9.646600E-01 |
| Stage1-vs-Stage3 |
5.013500E-02 |
| Stage1-vs-Stage4 |
1.173170E-04 |
| Stage2-vs-Stage3 |
2.088600E-01 |
| Stage2-vs-Stage4 |
8.097900E-03 |
| Stage3-vs-Stage4 |
7.415800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.36820000002014E-06 |
| Normal-vs-Asian |
1.21110010908865E-10 |
| Caucasian-vs-AfricanAmerican |
2.046000E-01 |
| Caucasian-vs-Asian |
4.628000E-01 |
| AfricanAmerican-vs-Asian |
5.348800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.33066907387547E-16 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
1.857110E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
5.76629999999856E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.035200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.361360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.752400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.491200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.584000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.207200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.023100E-03 |
| Classical-VS-Follicular |
2.687400E-01 |
| Classical-VS-Other |
1.172580E-01 |
| Classical-VS-Normal |
1.39677158728091E-12 |
| Tall-VS-Follicular |
2.576500E-03 |
| Tall-VS-Other |
5.711600E-01 |
| Tall-VS-Normal |
9.32587340685131E-15 |
| Follicular-VS-Other |
1.148570E-01 |
| Follicular-VS-Normal |
1.40089995159798E-09 |
| Other-VS-Normal |
2.02689999999617E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.22044604925031E-16 |
| Normal-vs-N1 |
1.11022302462516E-13 |
| N0-vs-N1 |
4.065600E-02 |
|
|
